Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger retinoic acid receptor alpha fusion protein

被引:151
作者
Dong, S
Zhu, J
Reid, A
Strutt, P
Guidez, F
Zhong, HJ
Wang, ZY
Licht, J
Waxman, S
Chomienne, C
Chen, Z
Zelent, A
Chen, SJ
机构
[1] SHANGHAI MED UNIV 2,RUI JIN HOSP,SAMUEL WAXMAN CANC RES FDN LAB,SHANGHAI INST HEMATOL,SHANGHAI 200025,PEOPLES R CHINA
[2] INST CANC RES,CHESTER BEATTY LABS,LEUKAEMIA RES FUND CTR,LONDON SW3 6JB,ENGLAND
[3] HOP ST LOUIS,CTR HAYEM,BIOL CELLULAIRE HEMATOPOIET LAB,F-75010 PARIS,FRANCE
[4] MT SINAI MED CTR,DEPT MED,DIV MED ONCOL,ROCHELLE BELFER CHEMOTHERAPY FDN LAB,NEW YORK,NY 10029
关键词
D O I
10.1073/pnas.93.8.3624
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Promyelocytic leukemia zinc finger-retinoic acid receptor alpha (PLZF-RAR alpha), a fusion receptor generated as a result of a variant t(11;17) chromosomal translocation that occurs in a small subset of acute promyelocytic leukemia (APL) patients, has been shown to display a dominant-negative effect against the wild-type RAR alpha/retinoid X receptor alpha (RXR alpha). We now show that its N-terminal region (called the POZ-domain), which mediates protein-protein interaction as well as specific nuclear localization of the wild-type PLZF and chimeric PLZF-RAR alpha proteins, is primarily responsible for this activity, To further investigate the mechanisms of PLZF-RAR alpha action, we have also studied its ligand-receptor, protein-protein, and protein-DNA interaction properties and compared them with those of the promyelocytic leukemia gene (PML)-RAR alpha, which is expressed in the majority of APLs as a result of t(15;17) translocation, PLZF-RAR alpha and PML-RAR alpha have essentially the same ligand-binding affinities and can bind in vitro to retinoic acid response elements (RAREs) as homodimers or heterodimers with RXR alpha. PLZF-RAR alpha homodimerization and heterodimerization with RXR alpha were primarily mediated by the POZ-domain and RAR alpha sequence, respectively, Despite having identical RAR alpha sequences, PLZF-RAR alpha and PML-RAR alpha homodimers recognized with different affinities distinct RAREs. Furthermore, PLZF-RAR alpha could heterodimerize in vitro with the wild-type PLZF, suggesting that it may play a role in leukemogenesis by antagonizing actions of not only the retinoid receptors hut also the wild-type PLZF and possibly other POZ-domain-containing regulators. These different protein-protein interactions and the target gene specificities of PLZF-RAR alpha and PML-RAR alpha may underlie, at least in part, the apparent resistance of APL with t(11;17) to differentiation effects of all-trans-retinoic acid.
引用
收藏
页码:3624 / 3629
页数:6
相关论文
共 35 条
  • [21] NUCLEAR RECEPTOR THAT IDENTIFIES A NOVEL RETINOIC ACID RESPONSE PATHWAY
    MANGELSDORF, DJ
    ONG, ES
    DYCK, JA
    EVANS, RM
    [J]. NATURE, 1990, 345 (6272) : 224 - 229
  • [22] FUSION OF A KINASE GENE, ALK, TO A NUCLEOLAR PROTEIN GENE, NPM, IN NON-HODGKINS-LYMPHOMA
    MORRIS, SW
    KIRSTEIN, MN
    VALENTINE, MB
    DITTMER, KG
    SHAPIRO, DN
    SALTMAN, DL
    LOOK, AT
    [J]. SCIENCE, 1994, 263 (5151) : 1281 - 1284
  • [23] NERVI C, 1992, CANCER RES, V52, P3687
  • [24] PMLRAR HOMODIMERS - DISTINCT DNA-BINDING PROPERTIES AND HETEROMERIC INTERACTIONS WITH RXR
    PEREZ, A
    KASTNER, P
    SETHI, S
    LUTZ, Y
    REIBEL, C
    CHAMBON, P
    [J]. EMBO JOURNAL, 1993, 12 (08) : 3171 - 3182
  • [25] CHROMOSOMAL TRANSLOCATIONS IN HUMAN CANCER
    RABBITTS, TH
    [J]. NATURE, 1994, 372 (6502) : 143 - 149
  • [26] REDNERRL, 1994, BLOOD, V87, pA375
  • [27] LEUKEMIA AND THE DISRUPTION OF NORMAL HEMATOPOIESIS
    SAWYERS, CL
    DENNY, CT
    WITTE, ON
    [J]. CELL, 1991, 64 (02) : 337 - 350
  • [28] SINGLE-STEP PURIFICATION OF POLYPEPTIDES EXPRESSED IN ESCHERICHIA-COLI AS FUSIONS WITH GLUTATHIONE S-TRANSFERASE
    SMITH, DB
    JOHNSON, KS
    [J]. GENE, 1988, 67 (01) : 31 - 40
  • [29] TONG JH, 1992, ONCOGENE, V7, P311
  • [30] ACUTE PROMYELOCYTIC LEUKEMIA
    WARRELL, RP
    DETHE, H
    WANG, ZY
    DEGOS, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (03) : 177 - 189